681 - 690 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Disease modifying therapies for Parkinson's disease: Novel targetsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 201Issue #:Start Page: 108839End Page: 108839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108839Citation Count: 4
-
RESTRICTEDTitle: New dopaminergic therapies for PD motor complicationsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 204Issue #:Start Page: 108869End Page: 108869Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108869Citation Count: 8
-
RESTRICTEDTitle: Etiology, pathological characteristics, and clinical management of black pleural effusionJournal Name: MedicinePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 8Start Page: e28130End Page: e28130Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1097/md.0000000000028130Best OA location URL: https://doi.org/10.1097/md.0000000000028130Citation Count: 6
-
RESTRICTEDTitle: The genetics of Parkinson diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 42Issue #:Start Page: 72End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.12.007Citation Count: 386
- Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillations2016RESTRICTEDTitle: Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillationsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 1Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26837Citation Count: 63
-
RESTRICTEDTitle: Targeting of the unfolded protein response (UPR) as therapy for Parkinson's diseaseJournal Name: Biology of the CellPublisher: WileyVol: 111Issue #: 6Start Page: 161End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/boc.201800068Citation Count: 36
-
RESTRICTEDTitle: Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and PathologyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 20Issue #: 1Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms20010141Best OA location URL: https://www.mdpi.com/1422-0067/20/1/141/pdf?version=1546425034Citation Count: 55
-
RESTRICTEDTitle: Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 16End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.016Best OA location URL: https://cris.maastrichtuniversity.nl/files/76214281/Leentjens_2019_Resting_state_fMRI_in_Parkinsons.pdfCitation Count: 129
-
RESTRICTEDTitle: Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?Journal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 7Start Page: 957End Page: 957Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12070957Best OA location URL: https://www.mdpi.com/2218-273X/12/7/957/pdf?version=1657271910Citation Count: 14
- Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?2021RESTRICTEDTitle: Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?Journal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 40End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12010040Best OA location URL: https://www.mdpi.com/2218-273X/12/1/40/pdf?version=1640831739Citation Count: 4